Dr Reddys Laboratories (RDY) Short-term Investments (2009 - 2026)

Dr Reddys Laboratories has reported Short-term Investments for 18 years, with the latest figure at $53.3 million in Q2 2026.

• On a quarterly basis, Short-term Investments rose 137.34% year-over-year to $53.3 million in Q2 2026; TTM through Jun 2026 was $53.3 million, a 137.34% increase from a year earlier, with the FY2026 full-year figure at $74.0 million, up 393.33% from the prior year.
• Short-term Investments was $53.3 million for Q2 2026 at Dr Reddys Laboratories, down from $75.5 million in the prior quarter.
• The five-year high for Short-term Investments was $75.5 million in Q1 2026, with the low at -$1.7 billion in Q3 2024.
• Average Short-term Investments over 5 years is -$303.8 million, with a median of $4.7 million recorded in 2024.
• The largest YoY upside for Short-term Investments was 475.58% in 2024 against a maximum downside of 105.35% in 2024.
• Over 5 years, Short-term Investments stood at -$1.1 billion in 2022, then surged by 100.35% to $3.7 million in 2023, then surged by 475.58% to $21.6 million in 2024, then surged by 63.91% to $35.4 million in 2025, then surged by 50.84% to $53.3 million in 2026.
• The last three Short-term Investments figures came in at $53.3 million (Q2 2026), $75.5 million (Q1 2026), and $35.4 million (Q4 2025), per Business Quant data.